CONEXA Investigacion Clinica S.A.

Buenos Aires, Buenos Aires 1012

1 studies enrolling now · 1 studies all time

What they study most

Atopic Dermatitis, Eczema

Studies at this site

• A Study to Assess the Long-Term Safety and Efficacy of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Enrolling by invitation